slu pp 332 with retatrutide SLU-PP-332 - Research Peptide The Synergistic Duo: Retatrutide &

PubMed Bock-Marquette I, Saxena A, White MD, et al

Two uncontrolled studies conducted in participants with cirrhosis found that L-carnitine supplementation was safe to use at doses of 0.9 to 1.2 g/day for eight weeks (125) and 1 g/day for 24 weeks (126) and might be considered to control the frequency of cramps

Eli Lilly and Novo Nordisk sell their drugs to patients directly for a major discount, but they still are prohibitively expensive: A months supply of Zepbound costs $500 a month when purchased straight from the manufacturer

Its worth monitoring these side effects reports, both because there still may be something genuinely concerning and because they may potentially present a good opportunity